The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Factors contributing to the ramifications of this disease as it stands include the socio-economic: overweight and obesity ...

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

The number of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic is rising in North Carolina, just as it is ...

Weight loss drugs, such as those containing GLP-1 agonists like Wegovy and Mounjaro, have emerged as effective tools for people struggling to lose ...

GLP-1 medications have become popular for weight loss, and for good reason—they can help regulate appetite and support weight ...

Women are increasingly turning to weight loss drugs like Wegovy and Mounjaro due to unrealistic beauty standards. Many use ...

They also don’t directly support behavior change, which Kathryn Ilonka Pollak, PhD, a professor in population health sciences ...

The conversation surrounding health care reform has intensified in recent years, revealing deep divides in how we view personal responsibility, government intervention and public health ...

The search for effective weight loss solutions has led to countless diet trends, fitness regimens, and medical interventions.

Research tells us that eating enough protein and staying physically active can be helpful in reducing the amount of non-fat ...